Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The FDA authorized the Ventana MET RxDx assay to information Emrelis use in sufferers with non-squamous non–small cell lung most cancers and excessive...
Scientific Transient: Implementation and Affected person Assist MethodsImportant Dialogue Subjects:Position of multidisciplinary care staff in affected person schooling and helpSignificance of early intervention...
Lumakras plus Vectibix confirmed improved total survival and response charges in KRAS G12C metastatic colorectal most cancers, although not statistically vital.Lumakras (sotorasib) plus...
